相关实验视频

Updated: May 10, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

针对Zfp36来对抗心脏缩:洞察铁亡途径

Mingyu Zhang¹, Xiaoxiang Guan², Zheng Dong¹

¹State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology (State Key Labratoray -Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.

Clinical and translational medicine

|February 25, 2025

概括

指蛋白36 (Zfp36) 通过抑制铁化,减轻心脏缩. 它准Ythdc2mRNA,防止谷氨耗尽并保持心脏功能,提供了一个新的治疗途径.

科学领域:

心血管生物学心血管生物学
疾病的分子机制.
细胞应激反应的应激反应

背景情况:

心脏缩在心力衰竭之前,这是死亡的主要原因.
指蛋白36 (Zfp36) 在心脏缩和铁死症中的作用基本上是未知的.
了解Zfp36的机制对于开发新疗法至关重要.

研究的目的:

调查Zfp36在心脏缩期间铁亡中的调节作用.
阐明Zfp36影响心脏缩的分子机制.
确定Zfp36作为潜在的治疗点.

主要方法:

单细胞测序以评估心脏缩中的Zfp36表达.
在体外研究中,使用用 ангиотензин II (Ang II) 治疗的心肌细胞.
在体内研究使用横向大动脉收缩 (TAC) 模型.
研究Zfp36,Ythdc2mRNA和SLC7A11mRNA之间的相互作用.

主要成果:

在心脏缩时,Zfp36的表达减少.
Zfp36 抑制铁化并降低心肌细胞和心肌组织中的过度缩表型.
Zfp36与Ythdc2mRNA结合,促进其降解,从而稳定SLC7A11mRNA并维持谷氨 (GSH) 水平.
费罗斯塔丁-1 缓解了 si-Zfp36 治疗细胞中的缩,证实了铁亡的参与.

结论:

通过Ythdc2/SLC7A11/GSH通路抑制铁亡,Zfp36可以减轻心脏缩.
这项研究揭示了心脏缩的新型调节途径.
Zfp36为心脏缩和相关心力衰竭提供了一个有前途的治疗标.

关键词:

有关RNA结合的RNA.这就是Ythdc2 .在 Zfp3636 中使用.心脏过度缩小的心脏过度缩小铁性化 (ferroptosis) 是一种

更多相关视频

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

相关概念视频

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...